Greenfield Jerry R, Frampton Ruth, Millard Kellie, Snaith Jennifer R
Garvan Institute of Medical Research, 384 Victoria St, Darlinghurst, NSW, 2010, Australia.
St. Vincent's Clinical Campus, Faculty of Medicine and Health, UNSW, Sydney, Australia.
Diabetes Ther. 2025 Feb;16(2):145-148. doi: 10.1007/s13300-024-01687-3. Epub 2025 Jan 6.
Type 1 diabetes is associated with excess cardiovascular risk, even after accounting for traditional cardiovascular risk factors, including glycaemia. Hence, there is an urgent need to document the metabolic abnormalities that contribute to the cardiovascular mortality gap in type 1 diabetes, and to examine whether cardioprotective type 2 diabetes medications prevent premature morbidity and mortality in this population.
1型糖尿病与心血管风险过高有关，即便在考虑了包括血糖在内的传统心血管风险因素之后亦是如此。因此，迫切需要记录导致1型糖尿病患者心血管死亡差距的代谢异常情况，并研究2型糖尿病的心脏保护药物能否预防该人群的过早发病和死亡。
